Skip to main content
All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biotechnology company.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $30,000.00 income · posted Apr 17, 2025

Official filing document

 Bills named in this filing 1
  • HR 1990
    American Innovation and R&D Competitiveness Act of 2025
 Lobbying activity 1
Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, 162(m), 174 and 41. (H.R. 1990)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem